---
title: ""
subtitle: ""
author: ""
date: "2016/12/12 (updated: `r Sys.Date()`)"
output:
  xaringan::moon_reader:
    seal: false
    css: ["default","metropolis","metropolis-fonts","hygge","https://afeld.github.io/emoji-css/emoji.css","libs/myassets/remark-css/header-footer.css"]
    lib_dir: libs
    self_contained: false
    nature:
      beforeInit: ["libs/myassets/remark-js/macro.js"]
      ratio: "16:9"
      highlightStyle: github
      highlightLines: true
      countIncrementalSlides: false

---

```{r setup, include=FALSE}
options(htmltools.dir.version = FALSE)
```


# Chapter 4:  Psychopharmacology

#### Principles of Psychopharmacology
#### Sites of Drug Action
#### Neurotransmitters and Neuromodulators

![:footer](chapter 4.1)

---

# Chapter 4:  Psychopharmacology

#### .bold[Principles of Psychopharmacology]
#### Sites of Drug Action
#### Neurotransmitters and Neuromodulators

![:footer](chapter 4.1)

---
name: 4-1-3
layout: true

# Principles of Psychopharmacology
### Definition of a Drug.
- exogenous chemical, that is not an essential 
   nutrient, that significantly alters function of 
   cells when taken in  low doses

### Definition of a Psychoactive Drug.
- drugs that alter mood, thought, or behavior
- most used to manage psychopathology
- some used recreationally

{{content}}

![:positionThis -275px, -150px, -20deg](.blue[a])
.blue[$$NaCl$$]

![:positionThis 20px, 100px, 40deg](.blue[a])
.blue[$$H_2O$$] 



---
name: 4-1-4
layout: true

# Principles of Psychopharmacology
### Pharmacokinetics.
- processes by which drugs are absorbed, distributed,
   metabolized, and excreted (ADME)

---
name: 4-1-5
layout: true

# Principles of Psychopharmacology
### Pharmacokinetics.
- route of administration

---
name: 4-1-6
layout: true

# Principles of Psychopharmacology
### Pharmacokinetics.
- route of administration, cocaine

---
name: 4-1-7
layout: true

# Principles of Psychopharmacology
### Pharmacokinetics.
- lipid solubility is the most important factor determining entry of drug through blood-brain-barrier for psychoactive drugs

---
name: 4-1-8
layout: true

# Principles of Psychopharmacology
### Pharmacokinetics.
.pull-left[
- rate of metabolism and excretion determines half-life
- however, some drugs broken down into biologically active molecules, extending effective lifespan
- individual differences in
  drug metabolism
]

---
name: 4-1-9
layout: true

# Principles of Psychopharmacology
### Pharmacodynamics.
- study of biochemical and physiological actions of a drug
- study of the relationship between drug dose and effect

---
name: 4-1-10
layout: true

# Principles of Psychopharmacology
### Pharmacodynamics.
- study of biochemical and physiological actions of a drug
- study of the relationship between drug dose and effect



---
name: 4-1-11
layout: true

# Principles of Psychopharmacology
### Pharmacodynamics.
- comparison of potencies

---
name: 4-1-12
layout: true

# Principles of Psychopharmacology
### Pharmacodynamics.
- non-montonic DRC reveals additional drug actions

---
name: 4-1-13
layout: true

# Principles of Psychopharmacology
### Pharmacodynamics.
- **therapeutic index** = margin of safety


---
name: 4-1-14
layout: true

# Principles of Psychopharmacology
### Pharmacodynamics.
- **agonists** = mimic or increase action of endogenous ligand (neurotransmitter, hormone, etc.)
- **antagonists** block or decrease action of endogenous ligand

---
name: 4-1-15
layout: true

# Principles of Psychopharmacology
### Pharmacodynamics.
- **affinity**: chemical attraction between ligand and receptor
- **efficacy** (intrinsic activity): ability of bound ligand to activate receptor


---
name: 4-1-16
layout: true

# Principles of Psychopharmacology
### Pharmacodynamics.  
.pull-left[
.small[**competitive** ligand (direct agonist or antagonist):
- binds to same receptor site as neurotransmitter]
]

.pull-right[
.small[**non-competitive** ligand (indirect direct agonist or antagonist):
- binds to different site on receptor
- modulates actions of neurotransmitter]
]


---
name: 4-1-17
layout: true

# Principles of Psychopharmacology
### Pharmacodynamics.
- drug efficacy in terms of maximal response
"- drug A is a full agonist; drug B is a partial agonist"

---
name: 4-1-18
layout: true

# Principles of Psychopharmacology
### Pharmacodynamics.
- **irreversible antagonist**: binds irreversibly to receptor or modified receptor
- **inverse agonist**: reverses endogenous action of receptor

---
name: 4-1-19
layout: true

# Principles of Psychopharmacology
### Pharmacodynamics.
- **sensitization** = physiological
    - compensation causing shift to the left in the DRC




---
name: 4-1-20
layout: true

# Principles of Psychopharmacology
### Pharmacodynamics.
- **tolerance** = physiological
    - compensation causing shift to the right in the DRC



---
name: 4-1-21
layout: true

# Principles of Psychopharmacology
### Pharmacodynamics.
- **cross sensitization**/**cross-tolerance** = repeated exposure to a drug induces increase/decrease in effectiveness of novel drug


---
name: 4-1-22
layout: true

# Principles of Psychopharmacology
### Pharmacodynamics.
- **withdrawal** = tolerance
    - cessation of drug taking




---
name: 4-1-23
layout: true


# Image Credits

- slide 3:	http://www.smartdrugs.co.uk/wp-content/uploads/2014/05/classes-of-smart-drugs.jpg
- slide 4:	http://www.montefiore.ulg.ac.be/services/stochastic/new/lib/exe/fetch.php?w=&h=&cache=cache&media=tfe11_kvsteen5.png
- slide 5:	http://psiwebsubr.org/SUBR/studyguides/4035studyguides/drugadministrationroutes.png
- slide 6:	Carlson, N.R. (2012). Physiology of Behavior, 11th ed. Pearson Publishing 
- slide 7:	http://psiwebsubr.org/SUBR/studyguides/4035studyguides/drugabsorbtion.png
- slide 8:	https://elcaminogmi.dnadirect.com/img/content/tests/drug_response/drug_metabolism.jpg
	https://elcaminogmi.dnadirect.com/img/content/tests/drug_response/normalDrugMetabolism.gif
- slide 9:	http://www.nature.com/ijir/journal/v19/n3/images/3901522f2.jpg
- slide 10-13: Breedlove, S.M., Watson, N.V. (2013). Biological Psychology: An Introduction to Behavioral, Cognitive, and Clinical Neuroscience, 7th ed. Sinauer Associates, Inc.
- slide 14-15: Breedlove, S.M., Watson, N.V. (2013). Biological Psychology: An Introduction to Behavioral, Cognitive, and Clinical Neuroscience, 7th ed. Sinauer Associates, Inc.
- slide 16:	Carlson, N.R. (2012). Physiology of Behavior, 11th ed. Pearson Publishing 
- slide 17:	Breedlove, S.M., Watson, N.V. (2013). Biological Psychology: An Introduction to Behavioral, Cognitive, and Clinical Neuroscience, 7th ed. Sinauer Associates, Inc.


![:footer](chapter 4.1)

---
name: 4-1-24
layout: true

# Image Credits

- slide 18:	 http://swift.cmbi.ru.nl/gv/GPCR/rvdkant/GPCR/images/ligands.jpg
- slide 19-21: Carlson, N.R. (2012). Physiology of Behavior, 11th ed. Pearson Publishing 
	Breedlove, S.M., Watson, N.V. (2013). Biological Psychology: An Introduction to Behavioral, Cognitive, and Clinical Neuroscience, 7th ed. Sinauer Associates, Inc.
- slide 22:	http://fenwayfocus.org/wp-content/uploads/2015/01/stock-footage-close-up-of-man-filling-the-syringe-up-with-heroin.jpg
	Carlson, N.R. (2012). Physiology of Behavior, 11th ed. Pearson Publishing 
	Breedlove, S.M., Watson, N.V. (2013). Biological Psychology: An Introduction to Behavioral, Cognitive, and Clinical Neuroscience, 7th ed. Sinauer Associates, Inc.

![:footer](chapter 4.1)



---
template: 4-1-3
![:positionImage 30%, 50%, 0deg, 100%](image1.png)

---
template: 4-1-4
![:positionImage 30%, 30%, 0deg, 110%](image2.png)

---
template: 4-1-5
![:positionImage 20%, 30%, 0deg, 90%](image3.png)

---
template: 4-1-6
![:positionImage 30%, 30%, 0deg, 70%](image4.png)

---
template: 4-1-7
![:positionImage 30%, 5%, 0deg, 80%](image5.png)

---
template: 4-1-8
![:positionImage 50%, 15%, 0deg, 90%](image6.jpg)

---
template: 4-1-8
count: false

.pull-right[
<iframe width="550" height="550" src="image_pie_9_12_js.html" frameborder="0"></iframe>
]
![:positionImage 50%, 15%, 0deg, 90%](image7.jpg)


---
template: 4-1-8
count: false

.pull-right[
<iframe width="550" height="550" src="image_pie_12_3_js.html" frameborder="0"></iframe>
]
![:positionImage 50%, 15%, 0deg, 90%](image7.jpg)


---
template: 4-1-8
count: false

.pull-right[
<iframe width="550" height="550" src="image_pie_3_6_js.html" frameborder="0"></iframe>
]
![:positionImage 50%, 15%, 0deg, 90%](image7.jpg)


---
template: 4-1-8
count: false

.pull-right[
<iframe width="550" height="550" src="image_pie_6_9_js.html" frameborder="0"></iframe>
]
![:positionImage 50%, 15%, 0deg, 90%](image7.jpg)


---
template: 4-1-9
![:positionImage 40%, 10%, 0deg, 350px](image10.jpg)
![:positionImage 40%, 60%, 0deg, 350px](image11.jpg)


---
template: 4-1-10
![:positionImage 35%, 30%, 0deg, 80%](image12.jpg)

![:positionText 45%, 40%, -25deg, 3, green](<b>dose-response function</b>)

---
template: 4-1-11
![:positionImage 20%, 30%, 0deg, 60%](image13.jpeg)


---
template: 4-1-12
![:positionImage 30%, 30%, 0deg, 60%](image14.jpeg)

---
template: 4-1-13

![:positionImage 20%, 35%, 0deg, 90%](image15.png)

---
template: 4-1-14
![:positionImage 40%, 10%, 0deg, 90%](image16.jpeg)


---
template: 4-1-15
![:positionImage 40%, 5%, 0deg, 150%](image17.jpg)
![:positionImage 40%, 60%, 0deg, 150%](image18.jpg)

.Large.bold[![:positionText 300%, 15%, 0deg, 3, red](agonist)]
.Large.bold[![:positionText 33%, 14%, 0deg, 3, red](Agonist)]
.Large.bold[![:positionText 33%, 67.5%, 0deg, 3, red](Antagonist)]

---
template: 4-1-16
![:positionImage 37%, 5%, 0deg, 100%](image19.jpeg)

![:positionText 300%, 15%, 0deg, 3, red](agonist)

![:positionText 90%, 14%, 0deg, 3, red](<b>competitive</b> </br>agonist or antagonist)

![:positionText 90%, 60%, 0deg, 3, red](<b>non-competitive</b> </br>agonist or antagonist)


---
template: 4-1-17
![:positionImage 30%, 30%, 0deg, 55%](image20.jpeg)


---
template: 4-1-18
![:positionImage 40%, 30%, 0deg, 100%](image21.jpeg)

---
template: 4-1-19
![:positionImage 40%, 60%, 0deg, 75%](image22.png)
![:positionImage 40%, 1%, 0deg, 90%](image23.jpg)

![:positionText 40%, 68%, 0deg, 3, red](<b>sensitized</b>)
![:positionText 40%, 77%, 0deg, 3, red](<b>baseline</b>)

---
template: 4-1-20
![:positionImage 40%, 60%, 0deg, 75%](image22.png)
![:positionImage 40%, 1%, 0deg, 90%](image24.jpg)


![:positionText 40%, 84%, 0deg, 3, red](<b>tolerant</b>)
![:positionText 40%, 77%, 0deg, 3, red](<b>baseline</b>)

---
template: 4-1-21
![:positionImage 40%, 50%, 0deg, 96.75%](image23.jpg)
![:positionImage 40%, 1%, 0deg, 90%](image24.jpg)



---
template: 4-1-22
![:positionImage 50%, 60%, 0deg, 85%](image22.png)
![:positionImage 15%, 60%, 0deg, 90%](image26.png)
![:positionImage 50%, 5%, 0deg, 100%](image24.jpg)

![:positionText 50%, 68%, 0deg, 3, red](<b>sensitized</b>)
![:positionText 50%, 79%, 0deg, 3, red](<b>baseline</b>)
![:positionText 50%, 87%, 0deg, 3, red](<b>tolerant</b>)

---
template: 4-1-23

---
template: 4-1-24
